Literature DB >> 4575653

Human breast cancer. A model for cancer immunology.

M M Black.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4575653

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


× No keyword cloud information.
  7 in total

Review 1.  Lymphatic invasion and metastasis.

Authors:  C van de Velde; I Carr
Journal:  Experientia       Date:  1977-07-15

2.  Immunological characterization of mononuclear cells and morphological findings in patients with mammary carcinoma.

Authors:  W Heidenreich; K Jagla; J Schüssler; P Börner; F Dehnhard; J Deinhardt; J Kalden; H H Peter; H Deicher
Journal:  J Cancer Res Clin Oncol       Date:  1979-09       Impact factor: 4.553

3.  Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study.

Authors:  K W Gilchrist; L Kalish; V E Gould; S Hirschl; J E Imbriglia; W M Levy; A S Patchefsky; D W Penner; J Pickren; J A Roth
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Possible immunological implications of an association between the stages of first and second independent breast cancers.

Authors:  M M Black; B F Hankey; J L Aron; P C Prorok
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

5.  Mononuclear stromal reactions in mammary carcinoma, with special reference to medullary carcinomas with a lymphoid infiltrate. Analysis of 108 cases.

Authors:  R Bässler; A M Dittmann; M Dittrich
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

6.  Axillary lymph node morphology in women with in situ breast carcinoma. An autopsy study.

Authors:  M Nielsen; L Christensen; J Jensen; J L Thomsen; J A Andersen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

7.  Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.

Authors:  D J Rowe; P C Beverley
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.